Irish scientists develop DNA-based cancer vaccine

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

6071
Regular Member


Date Joined Jul 2008
Total Posts : 112
   Posted 2/5/2010 6:16 AM (GMT -6)   
 
Irish scientists develop DNA-based cancer vaccine
05/02/2010 - 08:02:47
A DNA-based vaccine which is shown to destroy secondary prostate cancer has been successful in animal trials in Cork, according to research published today.
Ireland has a higher incidence and death rate for prostate cancer than the UK. The rate of the cancer is expected to rise by 275% between 2000 and 2020 due to our ageing population
Around 1,900 new cases of prostate cancer are diagnosed annually with 700 patients dying of the disease each year.
Localised prostate cancer is currently treated with surgery and radiotherapy, but there are limited options for cures for those with secondary prostate cancer.
DNA vaccines seek out any remaining cancer cells that have migrated to other parts of the body and destroy them, after treatment of the original cancer


Age 61 at DX
Biopsy 7/2008 Positive 1 of 12 cores positive 3+4 5% To 10%
Open Radical Prostatectomy 15/10/2008
Stage pt2c
Post op staging Gleason's Score 3+4=7
apical margin is focally positive
no extraprostatic extension
Seminal vesicles and lymph nodes clear
Catheter out on the 13/11/2008
4 week PSA < 0.1
26/1/2009  < 0.1
20/4/2009 < 0.1
11/6/2009 ultra sensitive psa 0.07
20/7/2009 < 0.1
26/8/09 Starting photon 3D CRT
13/10/09 Radiation Finished
25/11/09 ultra sensitive psa < 0.05
 






Post Edited (6071) : 2/5/2010 8:29:39 AM (GMT-7)

New Topic Post Reply Printable Version
Forum Information
Currently it is Monday, June 18, 2018 1:39 PM (GMT -6)
There are a total of 2,972,866 posts in 326,025 threads.
View Active Threads


Who's Online
This forum has 160864 registered members. Please welcome our newest member, Peter Clint.
444 Guest(s), 8 Registered Member(s) are currently online.  Details
DBwithUC, skeener, redskinsfan, Girlie, Jim48, TomC1962, njfillet, limey